A novel Death Effector Domain-containing protein was identified, DEDD2, which is closest in amino acid sequence homology to death effector domain-containing DNA-binding protein, DEDD. DEDD2 mRNA is expressed widely in adult human tissues with highest levels in liver, kidney, and peripheral blood leukocytes. DEDD2 interacts with FLIP, but not with Fas-associated death domain (FADD) or caspase-8. Overexpression of DEDD2 induces moderate apoptosis and results in substantial sensitization to apoptosis induced by Fas (CD95/ APO-1), tumor necrosis factor-related apoptosis-inducing ligand (TRAIL, Apo2L), or FADD. In contrast, Bax-or staurosporine-mediated cell death is not affected by expression of DEDD2. Fluorescence microscopy showed that overexpressed DEDD2 translocates to the nucleus, which is dependent on the presence of a bipartite nuclear localization signal in the DEDD2 protein. Mutagenesis studies revealed that the translocation of the DED of DEDD2 to the nucleus is essential for its proapoptotic activity. These findings suggest that DEDD2 is involved in the regulation of nuclear events mediated by the extrinsic apoptosis pathway.The initiation of death receptor-mediated apoptosis is characterized by the formation of signaling complexes that involve proteins containing the Death Domain (DD) 1 and Death Effector Domain (DED). Upon activation of death receptors such as Fas, the cytoplasmic adaptor molecule FADD interacts with the intracellular regions of the receptor proteins by homotypic binding of their DDs (1). Transduction of the apoptotic signal then depends on interaction of the DED in FADD with corresponding DEDs in pro-caspase-8, or pro-caspase-10, resulting in a protein complex that promotes trans-proteolysis of receptor-associated caspase pro-enzymes (2). The association of Fas (CD95/APO-1), FADD, and pro-caspase-8 has been termed "death-inducing signaling complex" (DISC) (3). The active caspase subunits are then released into the cytosol, where they cleave various substrates, including other caspases (e.g. caspase-3 (4)), cytoskeletal proteins (e.g. plectin (5)), or apoptosis effectors such as Bid (6, 7). Finally, the late stages of apoptosis are characterized by DNA fragmentation, which can be accomplished by endonucleases, such as caspase-activated DNase (8), and nuclear fragmentation associated with cleavage of nuclear scaffold proteins such as lamin (9).Besides the crucial role of DED proteins in the formation of the DISC and the activation of DED-containing initiator caspases, DEDs in viral or cellular proteins also have the ability to inhibit apoptosis. The proteins v-FLIP and c-FLIP (FLICE-inhibitory proteins) bind to the DEDs of pro-caspase-8 and -10, interfering with their activation in the DISC (10). This DED-mediated anti-apoptotic mechanism may be of particular importance, because overexpression of FLIP has been reported in several types of cancer (11,12).However, DED-containing proteins affect apoptotic signaling in addition to interfering with initial events of apoptosis, such as the DIS...